Metabolic Research Survodutide

What is Survodutide? Survodutide is an investigational dual agonist targeting both the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R). Developed by Boehringer Ingelheim and Zealand Pharma, it has been studied in preclinical and early clinical models for its potential effects on metabolic regulation, including energy balance and body weight modulation. Research has focused on its relevance to obesity and metabolic dysfunction-associated steatohepatitis (MASH), with ongoing studies exploring its mechanisms of action and therapeutic potential. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.

Note: This product is intended for research purposes only. Not for human consumption.

• Store in a cool, dry place away from direct sunlight

• Keep refrigerated after reconstitution

• Use within 30 days of reconstitution

• Keep out of reach of children

99%+ Purity Lab verified

3rd Party Tested Independent labs

Fast Shipping Ships within 24h

Secure Package Discreet delivery